The Drug Enforcement Administration (DEA) has proposed a regulation which will require an in-person visit between doctor and patient prior to the prescribing of certain drugs. While telehealth provides access for many patients with chronic disease or disability – there is the opportunity for abuse.
We believe a nuanced approach is needed, given that so many with chronic pain depend on these drugs, while we support the intent to require in-person visits before drugs are prescribed above recommended pain control dosages. The dosage prescribed for assisted suicide is massive, posing a greater risk to the community. This will help minimize any opportunity for abuse.
We join other opponents of assisted suicide providing comment on this new rule, knowing that it will result in strengthening the doctor/patient relationship and result in a more complete evaluation before drugs for the purpose of assisted suicide are prescribed.
Please submit your comments to the DEA by clicking here or on the button below.
Matt Vallière in the Los Angeles Times Thanks to the LA Times for sharing Matt’s letter, which strongly opposes assisted suicide laws. Read his letter to the editor below: Steve Lopez asks, “Will the option [of assisted suicide] be there for others?” To plaintiffs in the referenced lawsuit and many in the disability, older adult
Celebrating 33 Years of the ADA Today marks the 33rd anniversary of the signing of the Americans with Disabilities Act (ADA). On this day, July 26th, 1990, the ADA was signed and enshrined civil rights protections into law for people with disabilities. Today and every ADA anniversary, the Patients’ Rights Action Fund (PRAF) celebrates the
Advocates for Assisted Suicide Begin to Fear the Case in California Proponents of assisted suicide are beginning to write articles and speak up about their worries and opposition to the case filed in California to end assisted suicide. While the initial response to this groundbreaking case was severely delayed, opinion pieces and statements of opposition
